For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220322:nRSV5212Fa&default-theme=true
RNS Number : 5212F Softcat PLC 22 March 2022
22 March 2022
Softcat plc
Appointment of Non-Executive Director
Softcat plc ("Softcat" or the "Company"), a leading UK provider of IT
infrastructure technology and services, is pleased to announce the appointment
of Lynne Weedall as an independent non-executive Director of the Company.
Lynne brings significant experience to add to the Board of Softcat through a
number of prior senior positions in Human Resources. Previous senior executive
positions include Group People & Culture Director of Selfridges Group, and
Group Human Resources & Strategy Director of Carphone Warehouse.
Since leaving Selfridges, Lynne has taken on non-executive director roles at
Dr. Martens plc, Stagecoach Group plc and Treatt plc. She is chair of the
remuneration committee at Dr. Martens plc and Stagecoach Group plc and the
senior independent director at Dr. Martens plc and Treatt plc. Previous
non-executive roles include William Hill plc and Greene King plc.
It is intended that Lynne's appointment will become effective from 3 May 2022.
She will serve as Chair of the Board's Remuneration Committee, taking over
from Karen Slatford who will continue as senior independent Director and Chair
of the Nomination Committee.
Commenting on the appointment, Martin Hellawell, non-executive Chairman of
Softcat said:
"The Board has previously discussed the potential benefits of adding a further
non-executive Director, if that person would add further significant value to
the Board's effectiveness, skillset and expertise and would be a good fit.
Lynne certainly meets all these requirements as well as rebalancing the
workload of some of our other non-executive Directors. I am delighted that
she has agreed to join our Board.
Her insights from her executive career together with the significant
experience gained on the boards of listed companies will further strengthen
our Board. All of us at Softcat look forward to working with her and taking
advantage of her insights as we push ahead with our proven strategy for
growth.
I would like to thank Karen Slatford for chairing the Remuneration Committee
so professionally and effectively since her appointment in 2019 and look
forward to continuing to work closely with her in her Board roles at Softcat."
For further information, please contact:
Softcat plc
Graeme Watt, Chief Executive Officer +44 (0)1628 403 610
Graham Charlton, Chief Financial Officer
Media Enquiries ‐ FTI Consulting LLP
Ed Bridges/Matt Dixon +44 (0)20 3727 1000
Other information
The following details are required to be disclosed under 9.6.13R of the
Listing Rules of the Financial Conduct Authority in respect of other
directorships held by Lynne Weedall in a publicly quoted company at any time
in the previous five years:
· 11 January 2021 - current. Dr. Martens plc: senior independent
Director and Chair, Remuneration Committee.
· 1 August 2020 - current. Stagecoach Group plc: Non-executive
Director and Chair, Remuneration Committee.
· 6 April 2019 - current. Treatt plc: Senior Independent Director
and Chair, Nominations Committee.
· 1 July 2019 - 22 April 2021. William Hill plc: Non-executive
Director & Chair, Remuneration Committee.
· 11 October 2012 - 30 October 2019. Greene King plc: Non-executive
Director and Chair, Remuneration Committee.
Governance considerations and consequent Board composition
The Nomination Committee of Softcat worked with an external search firm on
this appointment. The search firm provided a list of highly experienced
candidates for the role, which included Lynne Weedall and each candidate was
reviewed or interviewed by the Committee. Lynne stood out as the best
candidate to further enhance the Board.
Since January 2021, Lynne and Softcat non-executive Director Robyn Perriss
have both served as independent non-executive Directors of Dr. Martens plc, a
UK listed company. However, they are not involved in executive duties for Dr.
Martens plc and each have a similar obligation to be independent for Dr.
Martens plc as they do for Softcat. Consequently, the Board of Softcat does
not consider that their position as independent non-executive Directors of the
Company are adversely impacted by their roles on the board of Dr. Martens plc.
The Board of Softcat is satisfied that they are both to be regarded as
independent under the 2018 UK Corporate Governance Code.
Following Lynne Weedall's appointment, the composition of the Board will be:
Non-executive Directors:
· Martin Hellawell - Chair
· Karen Slatford - Chair of the Nomination Committee and senior
independent Director
· Lynne Weedall - Chair of the Remuneration Committee
· Robyn Perriss - Chair of the Audit Committee
· Vin Murria - Designated Director for Workforce Engagement
Executive Directors:
· Graeme Watt - CEO
· Graham Charlton - CFO
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAPPUUAWUPPGBG